What are the first-line antibiotics for sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Antibiotics for Sinusitis

Amoxicillin is the first-line antibiotic for acute bacterial sinusitis in most patients, dosed at 500 mg twice daily for adults or 45 mg/kg/day in 2 divided doses for children, for 10-14 days. 1, 2

When to Use Standard-Dose Amoxicillin

  • Standard-dose amoxicillin (500 mg twice daily for adults; 45 mg/kg/day for children) is appropriate for uncomplicated acute bacterial sinusitis without recent antibiotic exposure or high-risk factors. 1, 2
  • This regimen targets the three most common pathogens: Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. 2, 3

When to Escalate to High-Dose Amoxicillin or Amoxicillin-Clavulanate

  • High-dose amoxicillin (875 mg twice daily for adults; 80-90 mg/kg/day for children) or amoxicillin-clavulanate should be used in high-risk situations: 1, 2

    • Age <2 years 1
    • Daycare attendance 1
    • Recent antibiotic use within 4-6 weeks 1, 2
    • Geographic areas with high prevalence of penicillin-resistant S. pneumoniae (>10-15% resistance) 1, 2
    • Moderate to severe disease presentation 1
  • The clavulanate component provides coverage against β-lactamase-producing H. influenzae (10-42% resistance to amoxicillin alone) and M. catarrhalis (nearly 100% β-lactamase positive). 1, 2

  • Recent evidence shows no significant benefit of high-dose over standard-dose amoxicillin-clavulanate in adults with clinically diagnosed acute sinusitis, though high-dose immediate-release formulations may provide more rapid symptom improvement at the cost of increased diarrhea (15.8% vs 4.8%). 4, 5

First-Line Options for Penicillin-Allergic Patients

  • For non-severe penicillin allergy (rash, mild reactions), second- or third-generation cephalosporins are safe and effective first-line alternatives: 1, 2

    • Cefuroxime-axetil 1
    • Cefpodoxime-proxetil 1, 2
    • Cefdinir 1, 2
    • Cefprozil 1
  • The risk of cross-reactivity between penicillins and second/third-generation cephalosporins is negligible for non-Type I hypersensitivity reactions. 1

  • For severe Type I penicillin allergy (anaphylaxis), respiratory fluoroquinolones are the preferred alternative: 1

    • Levofloxacin 500 mg once daily for 10-14 days 1, 6
    • Moxifloxacin 400 mg once daily for 10 days 1

Antibiotics to Avoid as First-Line Therapy

  • Azithromycin and other macrolides should NOT be used as first-line therapy due to resistance rates of 20-25% for both S. pneumoniae and H. influenzae. 1, 7, 3

  • Trimethoprim-sulfamethoxazole should be avoided due to high resistance rates (20-25%). 1

  • First-generation cephalosporins (e.g., cephalexin) are inappropriate due to inadequate coverage against H. influenzae, with nearly 50% of strains being β-lactamase producing. 1

  • Doxycycline has limited activity against H. influenzae and a predicted bacteriologic failure rate of 20-25%, making it suboptimal when better alternatives exist. 1

Treatment Duration

  • The standard duration is 10-14 days, or until symptom-free for 7 days. 1, 2, 3
  • Some studies suggest 5-7 day courses may have comparable efficacy with fewer side effects, though 10-14 days remains the guideline recommendation. 1, 8

When to Reassess and Switch Antibiotics

  • Reassess patients at 3-5 days: if no improvement, switch to a different antibiotic or re-evaluate the diagnosis. 1
  • At 7 days: confirm the diagnosis if symptoms persist or worsen. 1
  • For treatment failure after 3-5 days, switch to high-dose amoxicillin-clavulanate (if not already used) or a respiratory fluoroquinolone. 1

Critical Diagnostic Criteria Before Starting Antibiotics

  • Only prescribe antibiotics when acute bacterial sinusitis is confirmed by one of three patterns: 1

    • Persistent symptoms ≥10 days without improvement 1
    • Severe symptoms (fever ≥39°C with purulent discharge) for ≥3 consecutive days 1
    • "Double sickening" - worsening after initial improvement from viral URI 1
  • 98-99.5% of acute rhinosinusitis is viral and resolves spontaneously within 7-10 days without antibiotics. 1

Adjunctive Therapies

  • Intranasal corticosteroids (mometasone, fluticasone, budesonide) twice daily are strongly recommended as adjunctive therapy to reduce mucosal inflammation and improve symptom resolution. 1
  • Analgesics (acetaminophen, NSAIDs) for pain relief 1
  • Saline nasal irrigation for symptomatic relief 1
  • Decongestants (systemic or topical) as needed 1

Common Pitfalls to Avoid

  • Do not prescribe antibiotics for symptoms lasting <10 days unless severe symptoms are present. 1
  • Do not use mucus color alone to determine antibiotic need, as color reflects neutrophils, not bacteria. 1
  • Do not continue ineffective therapy beyond 3-5 days without reassessment. 1
  • Reserve fluoroquinolones for treatment failures or severe penicillin allergy to prevent resistance development. 1, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.